Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-19-023110
Filing Date
2019-09-09
Accepted
2019-09-09 15:00:22
Documents
1
Period of Report
2019-09-05

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3695
  Complete submission text file 0000899243-19-023110.txt   5192
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Issuer) CIK: 0001133416 (see all company filings)

EIN.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 5835 STRASBOURG COURT --- RENO NV 89511
Business Address
AMELIO GILBERT F (Reporting) CIK: 0001183247 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31791 | Film No.: 191083001